Research Topics
Genomes and Genes | John PerfectSummaryAffiliation: Duke University Medical Center Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Posaconazole as salvage therapy in patients with invasive fungal infections after solid organ transplantBarbara D Alexander
Division of Infectious Diseases and International Health, Box 3035, Duke University Medical Center, Durham, NC 27710, USA
Transplantation 86:791-6. 2008..In this post hoc analysis of a large, open-label, multicenter study, we evaluated efficacy and safety of posaconazole, a new extended-spectrum triazole, as salvage therapy for IFIs in SOT recipients...
The impact of the host on fungal infectionsJohn R Perfect
Division of Infectious Diseases, Duke University Medical Center, Durham, North Carolina 27710, USA
Am J Med 125:S39-51. 2012....
Cryptococcus neoformans: virulence and host defencesJ R Perfect
Division of Infectious Diseases, Duke University Medical Center, Durham, NC 27710, USA
Med Mycol 36:79-86. 1998..neoformans, the future of research in this area will require a certain critical mass of investigators to help share in the developmental costs which continue to occur...
Design of aerosolized amphotericin b formulations for prophylaxis trials among lung transplant recipientsJohn R Perfect
Division of Infectious Diseases, Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA
Clin Infect Dis 39:S207-10. 2004..Despite widespread use of amphotericin B aerosols, there are still few studies on how to validate their effectiveness or optimize pharmacokinetics...
Voriconazole treatment for less-common, emerging, or refractory fungal infectionsJohn R Perfect
Department of Medicine and Microbiology, Duke University Medical Center, Durham, North Carolina 27710, USA
Clin Infect Dis 36:1122-31. 2003..Voriconazole is an effective and well-tolerated treatment for refractory or less-common invasive fungal infections...
Treatment of non-Aspergillus moulds in immunocompromised patients, with amphotericin B lipid complexJohn R Perfect
Department of Medicine and Microbiology, Duke University Medical Center, Durham, North Carolina 27710, USA
Clin Infect Dis 40:S401-8. 2005..In an area with little guidance for therapy, the CLEAR data indicate that ABLC can be an effective broad-spectrum treatment choice for several invasive and refractory non-Aspergillus mould infections...
CryptococcosisJohn R Perfect
Department of Medicine, Division of Infectious Diseases, Duke University Medical Center, PO Box 3353, Durham, NC 27710, USA
Infect Dis Clin North Am 16:837-74, v-vi. 2002..This article collates and analyzes both new and old knowledge about the pathogen to help frame the meaning of human cryptococcosis as it starts to evolve in the new millennium...
New antifungal agentsJ R Perfect
Duke University Medical Center, Durham, NC, USA
Transpl Infect Dis 4:52-61. 2002
Cryptococcus neoformans: a sugar-coated killer with designer genesJohn R Perfect
Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA
FEMS Immunol Med Microbiol 45:395-404. 2005..C. neoformans has now become a primary model to study molecular fungal pathogenesis with the goal of identifying drug targets or vaccine strategies...
Nuances of new anti-Aspergillus antifungalsJ R Perfect
Duke University Medical Center, Durham, NC 27710, USA
Med Mycol 43:S271-6. 2005..However, significant progress has been made, and with careful use of the clinical tools available it is possible to make a successful impact on infection outcomes...
Cryptococcus neoformans: the yeast that likes it hotJohn R Perfect
Division of Infectious Diseases, Department of Medicine, Duke University Medical Center Durham, NC 27710, USA
FEMS Yeast Res 6:463-8. 2006....
Management of cryptococcosis: how are we doing?John R Perfect
Division of Infectious Disease, Duke University Medical Center, Durham, NC, United States
PLoS Med 4:e47. 2007
The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosisJ R Perfect
Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA
Clin Infect Dis 33:1824-33. 2001..Chronic necrotizing aspergillosis, aspergilloma, and allergic bronchopulmonary aspergillosis have variable management strategies and better short-term outcomes...
Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of americaJohn R Perfect
Division of Infectious Diseases, Duke University Medical Center, Durham, North Carolina 27710, USA
Clin Infect Dis 50:291-322. 2010..However, if the diagnosis is made early, if clinicians adhere to the basic principles of these guidelines, and if the underlying disease is controlled, then cryptococcosis can be managed successfully in the vast majority of patients...
Management of invasive mycoses in hematology patients: current approachesJohn R Perfect
Division of Infectious Disease, Duke University Medical Center, Durham, North Carolina 27710, USA
Oncology (Williston Park) 18:5-14. 2004..If patients are intolerant of or refractory to conventional therapy, effective alternatives include a lipid formulation of amphotericin B or an echinocandin...
Use of newer antifungal therapies in clinical practice: what do the data tell us?John R Perfect
Division of Infectious Diseases, Duke University Medical Center, Durham, North Carolina 27710, USA
Oncology (Williston Park) 18:15-23. 2004..Caspofungin is effective against both invasive aspergillosis and invasive candidiasis...
Fatty acid synthesis is essential for survival of Cryptococcus neoformans and a potential fungicidal targetMethee Chayakulkeeree
Department of Medicine, Division of Infectious Diseases, Duke University Medical Center, Durham, NC 27710, USA
Antimicrob Agents Chemother 51:3537-45. 2007..neoformans with a potential for synergistic behavior with azoles...
Antifungal resistance: the clinical frontJohn R Perfect
Division of Infectious Diseases, Duke University Medical Center, Durham, North Carolina, USA
Oncology (Williston Park) 18:15-22. 2004..Caspofungin and voriconazole show good activity against most Candida species and may be good alternatives for patients with Candida glabrata and Candida krusei infections and for those with relapsing infections...
Targeting the calcineurin pathway enhances ergosterol biosynthesis inhibitors against Trichophyton mentagrophytes in vitro and in a human skin infection modelChiatogu Onyewu
Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, NC 27710, USA
Antimicrob Agents Chemother 51:3743-6. 2007..The fluconazole-FK506 combination demonstrated the most obvious advantage over single-drug therapy by clearing conidia and protecting skin from damage at low drug concentrations...
Successful use of amphotericin B lipid complex in the treatment of cryptococcosisLarry M Baddour
Division of Infectious Disease, Mayo Clinic, Rochester, Minnesota 55905, USA
Clin Infect Dis 40:S409-13. 2005..A mean serum creatinine level decrease of 0.02 mg/dL occurred. ABLC was an effective treatment for cryptococcal infection in immunocompromised patients...
Characterization and regulation of the trehalose synthesis pathway and its importance in the pathogenicity of Cryptococcus neoformansElizabeth Wills Petzold
Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA
Infect Immun 74:5877-87. 2006..These studies in C. neoformans and previous studies in other pathogenic fungi support the view of the trehalose pathway as a selective fungicidal target for use in antifungal development...
Relationship of the glyoxylate pathway to the pathogenesis of Cryptococcus neoformansThomas H Rude
Division of Infectious Diseases, Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA
Infect Immun 70:5684-94. 2002..neoformans infection. Compounds that specifically target only ICL1 are unlikely to cripple C. neoformans growth in vivo...
Outcome of lung transplantation in patients with mycetomasDenis Hadjiliadis
Division of Pulmonary and Critical Care Medicine, Duke University Medical Center, Durham, NC 27710, USA
Chest 121:128-34. 2002..Additional research is needed to define the best therapeutic strategy for these patients during transplantation...
Cost of invasive fungal infections in the era of new diagnostics and expanded treatment optionsElizabeth Dodds Ashley
Division of Infectious Diseases and International Health, Department of Medicine, Duke University Medical Center, Durnham, North Carolina, USA
Pharmacotherapy 32:890-901. 2012..To determine the true institutional cost of treating invasive fungal infections in light of recent advances in diagnostic techniques and antifungal therapies for both treatment and prophylaxis of these infections...
Cytochrome c peroxidase contributes to the antioxidant defense of Cryptococcus neoformansSteven S Giles
Departments of Medicine and Molecular Genetics and Microbiology, Duke University Medical Center, P.O. Box 3353, Durham, NC 27710, USA
Fungal Genet Biol 42:20-9. 2005..neoformans...
Calcineurin is essential for survival during membrane stress in Candida albicansM Cristina Cruz
Department of Genetics, Duke University Medical Center, Durham, NC 27710, USA
EMBO J 21:546-59. 2002..albicans mutants, against other Candida species, or when combined with different azoles. We propose that calcineurin is part of a membrane stress survival pathway that could be targeted for therapy...
Differential effects of inhibiting chitin and 1,3-{beta}-D-glucan synthesis in ras and calcineurin mutants of Aspergillus fumigatusJarrod R Fortwendel
Department of Pediatrics, Duke University Medical Center, Durham, NC 27710, USA
Antimicrob Agents Chemother 53:476-82. 2009..Additionally, the calcineurin pathway elements cnaA and crzA play a major role in proper chitin and glucan incorporation into the A. fumigatus cell wall...
Mating-type-specific and nonspecific PAK kinases play shared and divergent roles in Cryptococcus neoformansPing Wang
Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, North Carolina 27710, USA
Eukaryot Cell 1:257-72. 2002....
Teaching old drugs new tricks: reincarnating immunosuppressants as antifungal drugsJill R Blankenship
Department of Molecular Genetics and Microbiology, Duke University Medical Center, Research Drive, Durham, NC 27710, USA
Curr Opin Investig Drugs 4:192-9. 2003..In summary, these highly successful pharmaceutical agents may find an even broader clinical application in combating infectious diseases...
Role of alternative oxidase gene in pathogenesis of Cryptococcus neoformansShamima Akhter
Department of Medicine, Division of Infectious Diseases, Duke University Medical Center, Durham, NC 27710, USA
Infect Immun 71:5794-802. 2003....
Cerebral phaeohyphomycosis in an immunodeficient child treated medically with combination antifungal therapyJane V Trinh
Department of Pediatrics, Duke University, Durham, North Carolina 27710, USA
Med Mycol 41:339-45. 2003..Despite the fatal outcome for our patient, we encourage other clinicians to try unique medical approaches for this historically life-threatening infection when adjunctive surgery is impossible...
Identification of Cryptococcus neoformans temperature-regulated genes with a genomic-DNA microarrayPeter R Kraus
Department of Molecular Genetics and Microbiology, 322 CARL Building, Box 3546, Research Dr, Duke University Medical Center, Durham, NC 27710, USA
Eukaryot Cell 3:1249-60. 2004..Our findings demonstrate the utility of even partial-genome microarrays for delineating regulatory cascades that contribute to microbial pathogenesis...
Calcineurin target CrzA regulates conidial germination, hyphal growth, and pathogenesis of Aspergillus fumigatusRobert A Cramer
Duke University Medical Center, Box 3499, Pediatric Infectious Diseases, Durham, NC 27710, USA
Eukaryot Cell 7:1085-97. 2008..In addition, the importance of CrzA to the production of disease is critical, and thus CrzA is an attractive fungus-specific antifungal target for the treatment of invasive aspergillosis...
The trehalose synthesis pathway is an integral part of the virulence composite for Cryptococcus gattiiPopchai Ngamskulrungroj
Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA
Infect Immun 77:4584-96. 2009..gattii in the invertebrate and mammalian hosts. These results highlight the central importance of this pathway in the virulence composites of both pathogenic cryptococcal species...
Transcriptional regulation of chitin synthases by calcineurin controls paradoxical growth of Aspergillus fumigatus in response to caspofunginJarrod R Fortwendel
Departments of Pediatrics, Duke University Medical Center, Durham, North Carolina 27710, USA
Antimicrob Agents Chemother 54:1555-63. 2010..Taken together, our data suggest a mechanistic role for A. fumigatus calcineurin signaling in the chitin biosynthetic response observed during paradoxical growth in the presence of high-dose caspofungin treatment...
Survival defects of Cryptococcus neoformans mutants exposed to human cerebrospinal fluid result in attenuated virulence in an experimental model of meningitisAnthony Lee
Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, NC 27710, USA
Infect Immun 78:4213-25. 2010..Our findings indicate that the genes required for C. neoformans survival in CSF ex vivo are necessary for survival and infection in this unique host environment...
The Cryptococcus neoformans catalase gene family and its role in antioxidant defenseSteven S Giles
Department of Cell Biology, Duke University Medical Center, Durham, NC 27710, USA
Eukaryot Cell 5:1447-59. 2006..neoformans possesses a robust antioxidant system, composed of functionally overlapping and compensatory components that provide protection against endogenous and exogenous oxidative stresses...
Cryptococcus neoformans {alpha} strains preferentially disseminate to the central nervous system during coinfectionKirsten Nielsen
Department of Molecular Genetics and Microbiology, 322 CARL Building, Research Drive, Duke University Medical Center, Durham, NC 27710, USA
Infect Immun 73:4922-33. 2005..These studies reveal the first virulence difference between congenic a and alpha strains in the most common pathogenic variety and suggest an explanation for the prevalence of alpha strains in clinical isolates...
Prevention and early treatment of invasive fungal infection in patients with cancer and neutropenia and in stem cell transplant recipients in the era of newer broad-spectrum antifungal agents and diagnostic adjunctsBrahm H Segal
Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY 14263, USA
Clin Infect Dis 44:402-9. 2007..Finally, we discuss the implications of newer antifungal agents and diagnostic adjuncts in the design of future clinical trials to evaluate prophylaxis and early prevention strategies...
Evaluation and management of fungal infections in immunocompromised patientsPriya Venkatesan
Duke University School of Medicine, Durham, NC 27710, USA
Dermatol Ther 18:44-57. 2005..Recent advances in antifungal therapy and their direct application to specific diseases provide important new approaches to this complex and often seriously ill patient population...
Same-sex mating and the origin of the Vancouver Island Cryptococcus gattii outbreakJames A Fraser
Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, North Carolina 27710, USA
Nature 437:1360-4. 2005..This has implications for the emergence of other microbial pathogens and inbreeding in host range expansion in the fungal and other kingdoms...
Antifungal therapy for invasive fungal diseases in allogeneic stem cell transplant recipients: an updateDustin T Wilson
Division of Infectious Diseases, Department of Medicine, Duke University Medical Center, PO Box 3353, Durham, NC 27710, USA
Mycopathologia 168:313-27. 2009..Finally, therapeutic drug monitoring of select antifungals (notably posaconazole and voriconazole) may play an increasing role due to significant interpatient variability in serum concentrations after standard doses...
Sexual cycle of Cryptococcus neoformans var. grubii and virulence of congenic a and alpha isolatesKirsten Nielsen
Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, North Carolina 27710, USA
Infect Immun 71:4831-41. 2003..Our studies highlight a role for sexual recombination in the evolution of a human fungal pathogen and provide a robust genetic platform to establish the molecular determinants of virulence...
The calcineurin target, Crz1, functions in azole tolerance but is not required for virulence of Candida albicansChiatogu Onyewu
Department of Molecular Genetics and Microbiology, 322 CARL Building, Box 3546, Research Drive, Duke University Medical Center, Durham, NC 27710, USA
Infect Immun 72:7330-3. 2004..Crz1 is a proposed downstream target of calcineurin based on studies of Saccharomyces cerevisiae. However, the in vitro phenotypes of C. albicans crz1/crz1 and calcineurin mutants differ and Crz1 is not required for virulence...
Aspergillus fumigatus calcipressin CbpA is involved in hyphal growth and calcium homeostasisNadthanan Pinchai
Department of Pediatrics, Duke University Medical Center, Durham, NC 27710, USA
Eukaryot Cell 8:511-9. 2009..fumigatus and provides evidence that CbpA may serve as a feedback inhibitor in some aspects of calcineurin functions...
Candida glabrata endophthalmitis following penetrating keratoplastyMatthew C Caldwell
Duke University Eye Center, Duke University Medical Center, Durham, North Carolina 27701, USA
J Cataract Refract Surg 35:598-602. 2009..In half the cases, there was a latent period of several months. These infections can be difficult to treat because C glabrata is often resistant to the antifungal agents commonly used to treat Candida albicans...
Surfactant protein D increases phagocytosis of hypocapsular Cryptococcus neoformans by murine macrophages and enhances fungal survivalScarlett Geunes-Boyer
Department of Cell Biology, Duke University Medical Center, Durham, North Carolina 27710, USA
Infect Immun 77:2783-94. 2009..These findings provide evidence that C. neoformans subverts host defense mechanisms involving surfactant, establishing a novel virulence paradigm that may be targeted for therapy...
Caspofungin for invasive candidiasis at a tertiary care medical centerAimee K Zaas
Division of Infectious Diseases and International Health, Duke University Medical Center, Durham, NC 27710, USA
Am J Med 119:993.e1-6. 2006..In this unselected review, caspofungin performed similarly as in clinical trials, and clinicians should consider caspofungin as first-line therapy for invasive candidiasis, particularly non-albicans species...
Molds: hyalohyphomycosis, phaeohyphomycosis, and zygomycosisSusanna Naggie
Division of Infectious Diseases, Department of Internal Medicine, Duke University Medical Center, Durham, NC 27710, USA
Clin Chest Med 30:337-53, vii-viii. 2009....
Comparative evaluation of Etest and sensititre yeastone panels against the Clinical and Laboratory Standards Institute M27-A2 reference broth microdilution method for testing Candida susceptibility to seven antifungal agentsBarbara D Alexander
Division of Infectious Diseases and International Health, Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA
J Clin Microbiol 45:698-706. 2007..However, further evaluation of their performance for determining the MICs of azoles, particularly for C. glabrata, is warranted...
Recent advances in the epidemiology, prevention, diagnosis, and treatment of fungal pneumoniaMelanie W Pound
Internal Medicine Infectious Diseases Academia, Division of Infectious Diseases, Duke University Medical Center, Durham, North Carolina 27710, USA
Curr Opin Infect Dis 15:183-94. 2002..Other echinocandin and triazole antifungals are under development in attempts to provide improved effective therapy for fungal pneumonia...
Calcineurin inhibition or mutation enhances cell wall inhibitors against Aspergillus fumigatusWilliam J Steinbach
Division of Pediatric Infectious Diseases, Duke University Medical Center, Durham, NC 27710, USA
Antimicrob Agents Chemother 51:2979-81. 2007..Quantification of 1,3-beta-d-glucan revealed decreased amounts in the calcineurin A (DeltacnaA) mutant. Calcineurin can be an excellent adjunct therapeutic target in combination with other cell wall inhibitors against A. fumigatus...
Phylogenomic analysis of non-ribosomal peptide synthetases in the genus AspergillusRobert A Cramer
Duke University Medical Center, Department of Molecular Genetics and Microbiology, Durham, NC 27710, USA
Gene 383:24-32. 2006..Further analysis of these genes and their peptide products may identify important roles for secondary metabolites produced by NRPS in Aspergillus physiology, ecology, and fungal pathogenicity...
Calcineurin controls growth, morphology, and pathogenicity in Aspergillus fumigatusWilliam J Steinbach
Department of Pediatrics, Division of Pediatric Infectious Diseases, Box 3499, Duke University Medical Center, Durham, North Carolina 27710, USA
Eukaryot Cell 5:1091-103. 2006..Our findings reveal that calcineurin appears to play a globally conserved role in the virulence of several pathogenic fungi and yet plays specialized roles in each and can be an excellent target for therapeutic intervention...
Disruption of a nonribosomal peptide synthetase in Aspergillus fumigatus eliminates gliotoxin productionRobert A Cramer
Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, NC 27710, USA
Eukaryot Cell 5:972-80. 2006..This result suggests that gliotoxin is not required for virulence in an immunosuppressed host with an invasive pulmonary infection...
Scedosporium prolificans osteomyelitis in an immunocompetent child treated with voriconazole and caspofungin, as well as locally applied polyhexamethylene biguanideWilliam J Steinbach
Department of Pediatrics, Duke University, Durham, North Carolina 27710, USA
J Clin Microbiol 41:3981-5. 2003..We also review the treatments and outcomes of 28 reported cases of osteomyelitis or septic arthritis caused by Scedosporium species in immunocompetent patients...
In vitro analyses, animal models, and 60 clinical cases of invasive Aspergillus terreus infectionWilliam J Steinbach
Department of Pediatrics, Duke University Medical Center, Durham, NC 27710, USA
Antimicrob Agents Chemother 48:3217-25. 2004
A randomized comparative study to determine the effect of omeprazole on the peak serum concentration of itraconazole oral solutionMelissa D Johnson
Division of Infectious Diseases and International Health, Duke University Medical Center, Box 3306 DUMC, Durham, NC 27710, USA
J Antimicrob Chemother 51:453-7. 2003..Omeprazole did not significantly affect the C(max), T(max) or AUC(0-8) of itraconazole or hydroxyitraconazole when administered as IOS...
Infections due to Aspergillus terreus: a multicenter retrospective analysis of 83 casesWilliam J Steinbach
Department of Pediatrics, Duke University Medical Center, Durham, NC 27710, USA
Clin Infect Dis 39:192-8. 2004..29; 95% CI, 0.15-0.56). Voriconazole is likely to be a better treatment choice for A. terreus infection than is a polyene...
Antifungal pharmacotherapy for invasive mould infectionsJason C Gallagher
Duke University Medical Center, Division of Infectious Diseases, Box 3353, Durham, NC 27710, USA
Expert Opin Pharmacother 4:147-64. 2003..The administration of an optimal fungicidal therapy early in the course of the illness and control of the underlying disease are vital to prevent complications and mortality from these tenacious mycoses...
Value of an inhalational model of invasive aspergillosisWilliam J Steinbach
Division of Pediatric Infectious Diseases, Box 3499, Duke University Medical Center, Durham, NC 27710, USA
Med Mycol 42:417-25. 2004....
Superoxide dismutase influences the virulence of Cryptococcus neoformans by affecting growth within macrophagesGary M Cox
Department of Medicine and Molecular Genetics and Microbiology, Duke University Medical Center, Durham, North Carolina, USA
Infect Immun 71:173-80. 2003..neoformans can compensate for the loss of the Cu,Zn SOD in vivo...
Caspofungin: first approved agent in a new class of antifungalsMelissa D Johnson
Division of Infectious Diseases and International Health, Duke University Medical Center, Box 3306 DUMC, Durham, NC 27710, USA
Expert Opin Pharmacother 4:807-23. 2003..However, more clinical data are needed to define its role as primary therapy for invasive aspergillosis, and its role in combination antifungal therapy...
Liposomal amphotericin B: clinical experience and perspectivesWinter J Gibbs
Department of Pharmacy Practice, Campbell University School of Pharmacy, Buies Creek
Expert Rev Anti Infect Ther 3:167-81. 2005..This review will focus primarily on recent liposomal amphotericin B experience and attempt to put its use into perspective considering other available antifungal agents...
In vitro interactions between antifungals and immunosuppressants against Aspergillus fumigatusWilliam J Steinbach
Division of Pediatric Infectious Diseases, Department of Pediatrics, Duke University Medical Center, Durham, North Carolina 27710, USA
Antimicrob Agents Chemother 48:1664-9. 2004..Our findings suggest a potential role for combination therapy with calcineurin pathway inhibitors and existing antifungal agents to augment activity against A. fumigatus...
A meta-analysis of medical versus surgical therapy for Candida endocarditisWilliam J Steinbach
Division of Infectious Diseases, Department of Pediatrics, Duke University, Durham, NC 27710, USA
J Infect 51:230-47. 2005..The optimal management of Candida infective endocarditis (IE) is unknown...
Novel modes of antifungal drug administrationRebekah R Arthur
Campbell University School of Pharmacy, Buies Creek, NC, USA
Expert Opin Investig Drugs 13:903-32. 2004..In contrast, the inhalation of antifungal aerosols, such as amphotericin B, is rapidly becoming a viable prophylactic option...
Is it time to abandon the use of amphotericin B bladder irrigation?Richard H Drew
Campbell University School of Pharmacy, Buies Creek, North Carolina, USA
Clin Infect Dis 40:1465-70. 2005..The patient may be best served by removal of the urinary catheter, if possible, rather than by instillation of bladder irrigation with amphotericin B...
Candida endocarditis: contemporary cases from the International Collaboration of Infectious Endocarditis Merged Database (ICE-mD)Daniel K Benjamin
Department of Pediatrics, Duke University, Durham, NC, USA
Scand J Infect Dis 36:453-5. 2004..We evaluated 16 patients with Candida IE nested within a cohort of 2,022 patients with IE. Prosthetic valve IE was more common in patients with Candida (50% vs 17%); mortality was 37% for patients with Candida...
New antifungal agentsIrene Lu
Division of Infectious Diseases and International Health, Duke University Medical Center, Durham, NC 27710, USA
Semin Respir Infect 17:140-50. 2002..Clinical antifungal drug resistance must be controlled by improving a series of antifungal therapeutic strategies...
Interlaboratory comparison of results of susceptibility testing with caspofungin against Candida and Aspergillus speciesFrank C Odds
Aberdeen Fungal Group, University of Aberdeen, Institute of Medical Sciences, Aberdeen AB25 2ZD, United Kingdom
J Clin Microbiol 42:3475-82. 2004....
Recent advances in antifungal pharmacotherapy for invasive fungal infectionsJason C Gallagher
Hahnemann University Hospital, Broad and Vine Sts, Mail Stop 451, Philadelphia, PA 19102, USA
Expert Rev Anti Infect Ther 2:253-68. 2004..Evidence-based studies using these new agents are accumulating, and they are assuming important roles in the pharmacotherapy of invasive fungal infections in seriously ill and complex patients...
Gpr1, a putative G-protein-coupled receptor, regulates morphogenesis and hypha formation in the pathogenic fungus Candida albicansTakuya Miwa
Division of Integrated Life Sciences, Graduate School of Biostudies, Kyoto University, Kitashirakawa Oiwake-cho, Sakyo-ku, Kyoto 606-8502, Japan
Eukaryot Cell 3:919-31. 2004....
Phenotypic and genotypic evaluation of fluconazole resistance in vaginal Candida strains isolated from HIV-infected women from BrazilMariceli A Ribeiro
Nucleo de Doencas Infecciosas, Centro Biomedico, Universidade Federal do Espirito Santo, Vitoria ES, Brazil
Med Mycol 43:647-50. 2005..albicans, azole resistance is associated with increased expression of CDR1...
Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trialThomas J Walsh
Immunocompromised Host Section, National Cancer Institute, Bethesda, MD 20892, USA
Clin Infect Dis 44:2-12. 2007..Current treatments provide limited benefit. Posaconazole is an extended-spectrum triazole with in vitro and in vivo activity against Aspergillus species...
Killing of Caenorhabditis elegans by Cryptococcus neoformans as a model of yeast pathogenesisEleftherios Mylonakis
Division of Infectious Diseases and Department of Molecular Biology, Massachusetts General Hospital, Boston 02114, USA
Proc Natl Acad Sci U S A 99:15675-80. 2002..neoformans with environmental predators such as free-living nematodes and amoebae and suggest that C. elegans can be used as a simple model host in which C. neoformans pathogenesis can be readily studied...
Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in childrenThomas J Walsh
Pediatric Oncology Branch, National Cancer Institute, Bethesda, MD 20892, USA
Pediatr Infect Dis J 21:240-8. 2002..To describe the safety and efficacy of voriconazole in children treated within the compassionate release program...
Antimicrobial resistance: resistance to antifungal agents: mechanisms and clinical impactZeina A Kanafani
American University of Beirut Medical Center, Beirut, Lebanon
Clin Infect Dis 46:120-8. 2008....
Aerosolized antifungal prophylaxis: the winds of change?John R Perfect
Clin Infect Dis 46:1409-11. 2008
Metabolic adaptation in Cryptococcus neoformans during early murine pulmonary infectionGuanggan Hu
Michael Smith Laboratories, The University of British Columbia, 2185 East Mall, Vancouver, BC, Canada
Mol Microbiol 69:1456-75. 2008..Taken together, the results reveal specific metabolic adaptations of C. neoformans during pulmonary infection and indicate a role for ACS1 and SNF1 in virulence...
Role of PLB1 in pulmonary inflammation and cryptococcal eicosanoid productionMairi C Noverr
Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Ann Arbor, Michigan 48109-0642, USA
Infect Immun 71:1538-47. 2003..These data suggest that cryptococcal PLB1 may act as a virulence factor by enhancing the ability to survive macrophage antifungal defenses, possibly by facilitating fungal eicosanoid production...
Identification of App1 as a regulator of phagocytosis and virulence of Cryptococcus neoformansChiara Luberto
Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, South Carolina, USA
J Clin Invest 112:1080-94. 2003..This study identifies App1 as a novel regulator of virulence for C. neoformans, and it highlights that internalization of fungal cells by AMs increases the dissemination of C. neoformans when the host cellular response is impaired...
Research Grants
- Pathobiology of C. neoformans in the Central Nervous SystemJohn R Perfect; Fiscal Year: 2010....
- Pathobiology of C. neoformans in the Central Nervous SystemJohn R Perfect; Fiscal Year: 2010....
- Pathobiology of C. neoformans in the Central Nervous SystemJohn Perfect; Fiscal Year: 2009....
- GENETIC & MOLECULAR BIOLOGY OF VIRULENCE IN C NEOFORMANSJohn Perfect; Fiscal Year: 2004..It is our hypothesis that beginning to understand the genetic regulation of C. neoformans during infection through this proposal will be a powerful tool to find targets to interrupt pathogenesis. ..
- CRYPTOCOCCUS NEOFORMANS--A MODEL FOR PATHOGENIC FUNGIJohn Perfect; Fiscal Year: 2003..This program emphasizes a focus on a single pathogen with a basic but broad-spectrum and highly interactive genomic approach to scientific investigations which can be extrapolated to other fungi. ..
- GENETIC/MOLECULAR BIOLOGY OF VIRULENCE IN C. NEOFORMANSJohn Perfect; Fiscal Year: 1993....
